The cost effectiveness of prenatal ultrasound screening for Trisomy 21
AbstractThe objective of this paper is to compare the cost effectiveness of opportunistic nuchal translucency ultrasound screening in pregnancy with alternative screening strategies for trisomy 21 in Australia. Methods used is a decision analytic model of various pregnancy screening strategies based on a systematic review of the literature on the effectiveness of nuchal translucency ultrasound and serum screening and costs based on current reimbursement fees. The model included the likelihood and cost of terminations following diagnostic testing and the associated risk of fetal loss. All prices are in 2001 Australian dollars.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by Monash University, Centre for Health Economics in its series Centre for Health Economics Working Papers with number 146/04.
Length: 13 pages
Date of creation: Oct 2003
Date of revision:
Contact details of provider:
Postal: Centre for Health Economics, Monash University, Building 75, Clayton, Victoria 3800, Australia
Web page: http://www.buseco.monash.edu.au/centres/che/
More information through EDIRC
Ultrasound; pregnancy; screening; cost effectiveness;
You can help add them by filling out this form.
reading list or among the top items on IDEAS.Access and download statisticsgeneral information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Teresa Cheong).
If references are entirely missing, you can add them using this form.